drugset / Trial / NCT00100984

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

NCT00100984

Phase 4 Terminated 8 enrolled Hoffmann-La Roche
RandomizedTreatment

Summary

The main objective of this study is to compare the safety and efficacy of an enfuvirtide containing regimen to a nucleoside combination regimen. Resistance information will also be collected.

Timeline

Start
2004-07-21
Primary completion
2005-07-16
Completion
2005-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Enfuvirtide Peptide